ICASA 2017 Abstract Presentation

• • • SAMUEL ODUONG’ SCHOOL DOTS PRESENTATION
    • PediacamDev-ICASA2017_PDB
    • ICASA 2017 _LIVING study interim results_OS_IA_final

PROF. NKANDU LUO (Chandelier)
Time: 10:45 – 12:15
HIV / AIDS Surveillance and Monitoring and Evaluation

• • • ICASA 2017 CHARLES UZANDE
    • ICASA 2017_ KP hot spot mapping and size estimations_Didier
    • Presentation motifs – ICASA 2017_YUYA
    • DR BATONA ICASA2017_FINAL 2
    • ICASA2017 Dr Thierno Cherif SY

PROF. SOULEYMAN MBOUP (Cinema Majestic)
Time: 10:45 – 12:15
Shared Responsibility and Partnership in HIV

• • • 17_ Bwalya_Zambia (oral) Final -1
    • Role’s ICASA 2017 Presentation Layout
    • Expanding Space for CSO Influence in Global Health – Presentation
    • ICASA 2017 Presentation by Samuel Osunleye

PROF. KADIO AUGUSTE (Salle Des Fêtes)
Time: 10:45 – 12:15
Policies, Programs and HIV Response

• • Daniel_Adeyinka_ICASA 2017 Presentation_slides_final
  • ICASO-EANNASO Quarter for Prevention Presentation
  • READY Teens Baseline Moses Bwire
  • Cahier retour ado Carmélita

Video:

• • • Evaluation du Passage du Lopinavir/r dans le Lait Maternel et Prédiction des Quantités Ingérées par le Nourrisson Allaité: Étude chez la Femme au Mali
    • Elimination of Mother-to-Child Transmission of HIV (eMTCT) in Western Nigeria: How Far Have We Gone?

PROF. FEMI SOYINKA (Palais Des Congrès)
Time: 12:45 – 14:15
Antiretroviral Therapy I

• • • A Fixed Dose Combination of Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate for the Initial Treatment of HIV-2 Infection: 48 Week Results from Senegal, West Africa

PROF. KADIO AUGUSTE (Salle Des Fêtes)
Time: 14:45 – 16:15
Socio-Cultural and Determinants of HIV

• • • Community Action Teams: Tacit Knowledge and Embeddedness as Drivers of Successful Community Mobilization for HIV & Aids Prevention
    • Household Economic Strengthening Interventions to Address HIV Prevention, Care, and Treatment Outcomes: A Comprehensive Evidence Review
    • Cracks in Teen Programming; Results from a Baseline Survey on Adolescent Sexual and Reproductive Health and Rights in Uganda

PROF. FEMI SOYINKA (Palais Des Congrès)
Time: 14:45 – 16:15
Antiretroviral Therapy II

• • • Superior Efficacy of Dolutegravir (DTG) Plus 2 NRTIs Compared with Lopinavir/ritonavir (LPV/r) Plus 2 NRTIs in Second-Line Treatment: 24 Week Interim and Sub Group Analyses from the DAWNING Study

Video:

• • • WEAC0703_Provision of Isoniazid Preventive Therapy to PLHIV in Swaziland- retrospective study

PROF. KADIO AUGUSTE (Salle Des Fêtes)
Time: 14:45 – 16:15
Non-Communicable Diseases and HIV Infection

• • • WEAB0904LipidProfileICASA2017BernardCerutti

Video:

• • • Improving Retention in Care among HIV Patients on Antiretroviral Therapy over Time: Elizabeth Glaser Pediatric AIDS Foundation Experience in Côte d’Ivoire
    • Improving Identification of Children Living with HIV in Zimbabwe through Use of an HIV Screening Algorithm
    • Evaluation de l’Apprentissage du VIH et du Traitement Antiretroviral chez les Enfants et Adolescents Infectes par le VIH a L’Hopital Laquintinie de Douala, Cameroun

PROF. SOULEYMAN MBOUP (Cinema Majestic)
Time: 12:45 – 14:15
HIV Biology and Co-infectios

• • • High Incidence of Emergent Gag Mutations during Second-line ART Failure in Nigeria
    • Next Generation Sequencing Improves Detection of HIV-1 Drug Resistance Mutations in Pre-Treated HIV Infected Patients
    • Sous-types Circulants de EBV et de HHV-6 chez les Pv-VIH au Burkina Faso, Impact sur le Taux de CD4 et la Charge Virale du VIH
    • Next Generation Sequencing Reveals a High Frequency of CXCR4 Utilizing Viruses in HIV-1 Chronically Infected Drug Experienced South African Individuals: A Retrospective Study

PROF. FEMI SOYINKA (Palais Des Congrès)
Time: 12:45 – 14:15
Diversified Prevention Tools for HIV / AIDS

• • • Study Participant Initiated Problem Solving Through Meetings: A Strategy to Enhance Adherence to the Vaginal Ring in a Microbicide Trial in South-western Uganda
    • “Why Should I Use a Condom when I Have a Wife”? Barriers and Motivations to PrEP Use among HIV-1 Serodiscordant Couples in the Nigeria PrEP Demonstration Project: A Qualitative Perspective

PROF. FEMI SOYINKA (Palais Des Congrès)
Time: 14:45 – 16:15
Sexually Transmitted Infections

• • • Gonococcal Antimicrobial Surveillance Programme (GASP) en Côte d’Ivoire
    • Voluntary Medical Male Circumcision: An Approach to Screen and Treat Clients for Sexually Transmitted Infections

PROF. NKANDU LUO (Chandelier)
Time: 16:45 – 18:15
Epidemiology of HIV. Comorbidity and Co-infections

• • 6Dec 1015 Luo room 2_Rodriguez SD Sys Lit Rev ICASA 4Dec17
  • Providing HIV Testing and Counselling to Patients with Presumptive Tuberculosis in Côte d’Ivoire, 2016

Video: